NexGard Spectra refers to combined antiparasitic drugs. NexGard Spectra is available in five dosages: tablets weighing 0.5 1.0 2.0 4.0 and 8.0 g, packaged in 3 tablets in blisters made of polyvinyl chloride and aluminum foil on a paper basis, which are individually packed in cardboard boxes along with instructions for use. In appearance, the drug is a round-shaped tablet from light pink to dark pink with reddish-brown blotches. NexGard Spectra as active ingredients contains afoxolaner – 1.87% (in 1 tablet 9.4 mg, 18.8 mg, 37.5 mg, 75 mg and 150 mg) and milbemycin oxime – 0.38% (in 1 tablet 1.9 mg, 3.8 mg, 7.5 mg, 15 mg and 30 mg), as well as auxiliary substances: corn starch, soy protein flour, a food additive with the aroma and taste of stewed beef, povidone E1201, macrogol 400, macrogol 4000, macrogol 15 hydroxystearate, glycerol, medium chain triglyceride, citric acid monohydrate, butylhydroxytoluene. Pet owners and veterinarians who have additional questions can contact call 24.NexGard Spectra Chewable tablets for fleas and ticksExtra Small Dogs 2-3.5 kg, 3 tabįor the treatment and prevention of parasitic diseases in dogs Composition and form of release.If you prefer to report directly to the FDA, or want additional information about adverse drug experience reporting for animal drugs, see How to Report Animal Drug and Device Side Effects and Product Problems.Zoetis (Simparica, Revolution Plus): 88.To report suspected adverse drug events for these products and/or obtain a copy of the Safety Data Sheet (SDS) or for technical assistance, contact the appropriate manufacturers at the following phone numbers:.You can do this by reporting to the drugs’ manufacturers, who are required to report this information to the FDA, or by submitting a report directly to the FDA. The FDA continues to monitor adverse drug event reports for these products and encourages pet owners and veterinarians to report adverse drug events.If your dog or cat experiences any adverse event while using an isoxazoline product, first consult your veterinarian.What should I do if my pet has an adverse drug event while using an isoxazoline product? These products are approved for the treatment and prevention of flea infestations, and the treatment and control of tick infestations. Some are also approved for treatment and control of ear mite infestations and some gastrointestinal parasite infections, and a few are also approved for prevention of heartworm disease.Revolution Plus (selamectin and sarolaner) topical solution for cats.Simparica Trio (sarolaner, moxidectin and pyrantel) tablets for dogs.Nexgard Combo (esafoxolaner, eprinomectin, and praziquantel) topical solution for cats.Nexgard Plus (afoxolaner, moxidectin, and pyrantel) chewable tablets for dogs.Credelio (lotilaner) tablets for dogs and cats.Bravecto 1-month (fluralaner) tablets for dogs.Bravecto Plus (fluralaner and moxidectin) topical solution for cats.Bravecto (fluralaner) topical solution for cats and dogs.The FDA-approved drugs in this class are. ![]() ![]() What products are in the isoxazoline class? Some flea and tick products are regulated by the FDA and some are regulated by the Environmental Protection Agency. You can discuss all options with your veterinarian to choose the right product for your pet. Many products are available for prevention and control of flea and tick infestations.Although most dogs and cats haven’t had neurologic adverse reactions, seizures may occur in animals without a prior history.Isoxazoline products have been associated with neurologic adverse reactions, including muscle tremors, ataxia, and seizures in some dogs and cats.The FDA considers products in the isoxazoline class to be safe and effective for dogs and cats but is providing this information so that pet owners and veterinarians can take it into consideration when choosing flea and tick products for their pets.Although these products can and have been safely used in the majority of dogs and cats, pet owners should consult with their veterinarian to review their patients’ medical histories and determine whether a product in the isoxazoline class is appropriate for their pet.The FDA is alerting pet owners and veterinarians of the potential for neurologic adverse events in dogs and cats when treated with drugs that are in the isoxazoline class.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |